TSH Biopharm Corporation Limited (TPEX:8432)

TSH Biopharm Corporation Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,150	2,354	1,931	1,826	1,709	2,262
Market Cap Growth	-2.78%	21.87%	5.78%	6.85%	-24.45%	-24.97%
Enterprise Value	1,514	1,785	1,230	1,111	926	1,588
Last Close Price	56.00	58.74	47.23	43.09	38.91	49.22
PE Ratio	17.23	20.81	31.16	29.50	36.27	36.73
PS Ratio	1.69	2.11	2.38	2.46	4.13	5.05
PB Ratio	1.26	1.45	1.53	1.51	1.58	2.01
P/TBV Ratio	1.87	2.13	1.83	1.77	1.58	2.02
P/FCF Ratio	12.51	12.93	67.79	59.62	25.01	233.28
P/OCF Ratio	12.21	12.81	57.02	53.15	24.87	194.79
EV/Sales Ratio	1.19	1.60	1.52	1.50	2.24	3.55
EV/EBITDA Ratio	6.79	9.64	15.84	14.02	15.21	19.93
EV/EBIT Ratio	7.43	10.51	19.33	16.83	16.65	21.37
EV/FCF Ratio	8.81	9.81	43.18	36.28	13.55	163.76
Debt / Equity Ratio	0.01	0.01	0.01	0.05	0.00	0.01
Debt / EBITDA Ratio	0.08	0.10	0.09	0.73	0.07	0.10
Debt / FCF Ratio	0.11	0.11	0.26	2.06	0.07	0.91
Asset Turnover	0.65	0.69	0.57	0.57	0.35	0.36
Inventory Turnover	3.41	3.62	3.64	3.89	2.20	2.38
Quick Ratio	4.12	5.32	7.35	4.96	9.72	8.49
Current Ratio	4.77	6.25	8.34	5.56	10.72	9.57
Return on Equity (ROE)	9.62%	9.29%	5.24%	5.76%	4.26%	5.47%
Return on Assets (ROA)	6.49%	6.55%	2.81%	3.17%	2.90%	3.72%
Return on Invested Capital (ROIC)	20.89%	21.06%	11.30%	13.19%	11.14%	13.84%
Return on Capital Employed (ROCE)	11.90%	10.40%	5.00%	5.40%	5.10%	6.60%
Earnings Yield	5.81%	4.81%	3.21%	3.39%	2.76%	2.72%
FCF Yield	7.99%	7.73%	1.47%	1.68%	4.00%	0.43%
Dividend Yield	3.79%	3.61%	2.71%	3.71%	3.85%	3.66%
Payout Ratio	65.11%	43.46%	99.11%	93.06%	146.72%	112.26%
Buyback Yield / Dilution	-0.05%	-0.04%	0.05%	-0.05%	-0.01%	-
Total Shareholder Return	3.74%	3.57%	2.76%	3.66%	3.85%	3.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.